+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Eluting Stent"

From
Stents: Technologies and Global Markets 2022-2027 - Product Thumbnail Image

Stents: Technologies and Global Markets 2022-2027

  • Report
  • June 2022
  • 152 Pages
  • Global
From
Implantable Drug Delivery Devices Global Market Report 2024 - Product Thumbnail Image

Implantable Drug Delivery Devices Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
Bioabsorbable Stents Global Market Report 2024 - Product Thumbnail Image

Bioabsorbable Stents Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
Implantable Drug Delivery Devices Market 2025-2033 - Product Thumbnail Image

Implantable Drug Delivery Devices Market 2025-2033

  • Report
  • March 2025
  • 144 Pages
  • Global
From
Indonesia Stent Market, Competition, Forecast & Opportunities, 2028 - Product Thumbnail Image

Indonesia Stent Market, Competition, Forecast & Opportunities, 2028

  • Report
  • October 2023
  • 80 Pages
  • Indonesia
From
From
Loading Indicator

The Drug Eluting Stent (DES) market is a subset of the drug delivery market. DES are medical devices used to treat coronary artery disease. They are inserted into the artery and release a drug over time to prevent the artery from narrowing again. The DES market has grown in recent years due to the increasing prevalence of cardiovascular diseases and the need for more effective treatments. The DES market is expected to continue to grow as new technologies are developed and the demand for more effective treatments increases. Some of the major players in the DES market include Abbott, Boston Scientific, Medtronic, Biotronik, and Terumo. Show Less Read more